Delivery of oligonucleotide‐based therapeutics: challenges and opportunities

Abstract Nucleic acid‐based therapeutics that regulate gene expression have been developed towards clinical use at a steady pace for several decades, but in recent years the field has been accelerating. To date, there are 11 marketed products based on antisense oligonucleotides, aptamers and small i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Suzan M Hammond, Annemieke Aartsma‐Rus, Sandra Alves, Sven E Borgos, Ronald A M Buijsen, Rob W J Collin, Giuseppina Covello, Michela A Denti, Lourdes R Desviat, Lucía Echevarría, Camilla Foged, Gisela Gaina, Alejandro Garanto, Aurelie T Goyenvalle, Magdalena Guzowska, Irina Holodnuka, David R Jones, Sabine Krause, Taavi Lehto, Marisol Montolio, Willeke Van Roon‐Mom, Virginia Arechavala‐Gomeza
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Nature 2021-04-01
Colecção:EMBO Molecular Medicine
Assuntos:
delivery
oligonucleotides
preclinical models
RNA therapeutics
safety
Acesso em linha:https://doi.org/10.15252/emmm.202013243
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados